Stock Events

BioGaia 

€10.05
0
+€0.15+1.52% Friday 06:06

Statistics

Day High
10.05
Day Low
10.05
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
995.62M
P/E Ratio
28.29
Dividend Yield
1.61%
Dividend
0.16

Upcoming

22
OCT
Earnings
 
8
MAY 25
Dividend Ex
Estimated
 
15
MAY 25
Dividend Payment
Estimated
 
8
MAY 26
Dividend Ex
Estimated
 
15
MAY 26
Dividend Payment
Estimated
 

Dividends

1.61%Dividend Yield
May 24
€0.43
May 24
€0.16
May 23
€0.13
May 23
€0.13
May 22
€0.14
10Y Growth
0.91%
5Y Growth
1.62%
3Y Growth
6.32%
1Y Growth
25.04%

Earnings

22OctExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
0
0.37
0.74
1.11
Expected EPS
0.81563104738
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BGLA.F. It's not an investment recommendation.
Alphabet
72554
GOOGL
Apple
63389
AAPL
Microsoft
59081
MSFT
Amazon
54705
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Daiichi Sankyo.
DSKYF
Mkt Cap80.34B
Danisco (DuPont Nutrition & Biosciences) offers probiotic strains that compete directly with BioGaia's products in the dietary supplement market.
Chervon Limited
CHRHF
Mkt Cap868.79M
Chr. Hansen Holding A/S specializes in probiotic and natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries, directly competing with BioGaia's probiotic offerings.
Novonesis AS
NVZMY
Mkt Cap32.28B
Novozymes provides bioinnovation, including probiotics that can be used in various applications, competing in the same space as BioGaia.
Kerry
KRYAF
Mkt Cap17.15B
Kerry Group offers nutritional and functional ingredients, including probiotics, that compete with BioGaia's range of products.
BeiGene
BGNE
Mkt Cap21.34B
BeiGene is involved in biopharmaceuticals, and while its focus is more on oncology, its expansion into health and wellness products could position it as a competitor to BioGaia.
Herbalife
HLF
Mkt Cap821.86M
Herbalife Nutrition offers dietary supplements, including probiotics, competing in the same market as BioGaia.
Amarin
AMRN
Mkt Cap257.19M
Amarin Corporation focuses on cardiovascular health products, but its interest in overall health could lead to expansion into areas like probiotics, making it a potential competitor to BioGaia.

About

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.
Show more...
CEO
Mr. Peter Rothschild M.Sc. Econ., MBA
Employees
220
Country
SE
ISIN
SE0017769995
WKN
000A3DL7T

Listings

F
DE
BGLA.F
US
BIOGY
ST
Sweden
BIOG-B.ST
US
BGLAF